Elevated LDL-c may warn of the risk of gallbladder stones in the patients with metabolic dysfunction-associated steatotic liver disease: A case-control study - 14/05/24
Highlights |
• | NAFLD linked to new-onset GSD, revealing liver-gallbladder connection. |
• | Hypercholesterolemia independently increases GSD risk, crucial finding. |
• | Elevated serum LDL-c potentially critical risk factor in NAFLD patients. |
• | Factors influencing new-onset GSD: waist circumference, cholesterol, HDL-c. |
• | Study underscores cholesterol and LDL-c monitoring in NAFLD individuals. |
Abstract |
Purpose |
This study aimed to explore the relationship between metabolic dysfunction-associated steatotic liver disease (MASLD) and the development of new-onset gallbladder stone disease (GSD) and to identify factors that influence the occurrence of new-onset GSD in patients with MASLD.
Methods |
In this retrospective case-control study, patients who underwent asymptomatic GSD screening during annual routine health check-ups at two hospitals in China between August 2017 and July 2022 were included. Patients with new-onset GSD and controls without GSD were matched 1:1 based on age, sex, race, occupation, diet, drinking habits, systolic blood pressure, diastolic blood pressure, and fasting blood glucose levels.
Results |
The study comprised 1200 patients with new-onset GSD and 1200 controls without GSD. Patients with new-onset GSD had higher rates of MASLD (33.8% vs. 22.2 %, P < 0.001) and hypercholesterolemia (12.6% vs. 7.2 %, P < 0.001) compared to controls. Waist circumference (WC) (OR = 1.042, 95 % CI: 1.022–1.063, P < 0.001), high-density lipoprotein cholesterol (HDL-c) (OR = 0.048, 95 % CI: 0.037–0.062, P < 0.001), triglycerides (OR = 0.819, 95 % CI: 0.699–0.958, P = 0.013), and hypercholesterolemia (OR = 5.023, 95 % CI: 2.735–9.225, P < 0.001) were independently associated with new-onset GSD. Among patients with MASLD, WC (OR = 1.075, 95 % CI: 1.026–1.127, P = 0.003), total cholesterol (TC) (OR = 2.094, 95 % CI: 1.259–3.484, P = 0.004), HDL-c (OR = 0.088, 95 % CI: 0.054–0.142, P < 0.001), and low-density lipoprotein cholesterol (LDL-c) (OR = 4.056, 95 % CI: 2.669–6.163, P < 0.001) were independently associated with new-onset GSD.
Conclusions |
The findings indicate that hypercholesterolemia is independently associated with GSD. Among patients with MASLD, hypercholesterolemia also showed an independent association with GSD. Notably, this study is the first to identify serum LDL-c levels as potentially the most significant risk factor for GSD, highlighting that elevated LDL-c could serve as an important indicator for individuals with MASLD.
Le texte complet de cet article est disponible en PDF.Keywords : Metabolic dysfunction-associated steatotic liver disease, Gallstone disease, Low-density lipoprotein cholesterol, Case-control
Plan
Vol 48 - N° 6
Article 102363- juin 2024 Retour au numéro
Article précédent
- A retrospective study to determine the correlation among HBV PreS1 antigen, HBV e antigen, alanine aminotransferase, and HBV DNA
- Sihan Du, Ximin Shen, Yi Sun, Jia Li, Juan Wang, Yiting Cai, He Li
- Study of non-alcoholic fatty pancreatic disease among the Egyptian population and the value of serum fatty acid binding protein-1 (FABP-1) as a non-invasive biomarker
- Hussein Hassan Okasha, Mona A Hegazy, Olfat Shaker, Yasmine Abd Elfatah, Shereen Sadik El-Sawy, Dalia Abdelfatah, Abeer Abdellatef
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?